Control of onchocerciasis in Africa: Threshold shifts, breakpoints and rules for elimination

International Journal for Parasitology

Volumn 41, Issue 5, 2011, Pages 581-589

  Duerr, Hans P ^a   Raddatz, Günter ^a   Eichner, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Africa; Breakpoints; Elimination; Epidemiology; Mathematical model; Onchocerciasis

Indexed keywords

IVERMECTIN;

EPIDEMIOLOGY; IVERMECTIN; NUMERICAL MODEL; ONCHOCERCIASIS; PARASITE; THRESHOLD;

AFRICA; ARTICLE; BITE; CONTROLLED STUDY; FEMALE; HUMAN; INSECT BITE; MALI; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE CONTROL; PARASITE TRANSMISSION; PARASITE VECTOR; PREDICTION; SENEGAL; STOCHASTIC MODEL;

ADULT; AFRICA; ANIMALS; ANTHELMINTICS; FEMALE; HUMANS; INFECTION CONTROL; IVERMECTIN; MALE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; TREATMENT OUTCOME; YOUNG ADULT;

MALI; SENEGAL;

EID: 79952707180     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.12.009     Document Type: Article

References (29)

1. Abiose A., Homeida M., Liese B., Molyneux D., Remme H. Onchocerciasis control strategies. Lancet 2000, 356:1523-1524.
2. Albiez E.J., Walter G., Kaiser A., Ranque P., Newland H.S., White A.T., Greene B.M., Taylor H.R., Buttner D.W. Histological examination of onchocercomata after therapy with ivermectin. Trop. Med. Parasitol. 1988, 39:93-99.
3. Alley W.S., van Oortmarssen G.J., Boatin B.A., Nagelkerke N.J., Plaisier A.P., Remme J.H., Lazdins J., Borsboom G.J., Habbema J.D. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health 2001, 1:12.
4. Anderson R.M., May R.M. Infectious Diseases of Humans: Dynamics and Control 1991, Oxford University Press, Oxford.
5. Awadzi K., Attah S.K., Addy E.T., Opoku N.O., Quartey B.T. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:189-194.
6. Basáñez M.G., Ricardez-Esquinca J. Models for the population biology and control of human onchocerciasis. Trends Parasitol. 2001, 17:430-438.
7. Chavasse D.C., Post R.J., Lemoh P.A., Whitworth J.A. The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone. Trop. Med. Parasitol. 1992, 43:256-262.
8. Cupp E.W., Cupp M.S. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am. J. Trop. Med. Hyg. 2005, 73:1159-1161.
9. Cupp E.W., Sauerbrey M., Richards F. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(R)) monotherapy. Acta Trop. 2010, (Epub ahead of print). 10.1016/j.actatropica.2010.08.009.
10. Dadzie Y., Neira M., Hopkins D. Final report of the conference on the eradicability of onchocerciasis. Filaria J. 2003, 2:2.
11. Diawara L., Traore M.O., Badji A., Bissan Y., Doumbia K., Goita S.F., Konate L., Mounkoro K., Sarr M.D., Seck A.F., Toe L., Touree S., Remme J.H. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl. Trop. Dis. 2009, 3:e497.
12. Duerr H.P., Dietz K., Schulz-Key H., Büttner D.W., Eichner M. Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:242-250.
13. Duerr H.P., Dietz K., Eichner M. Determinants of the eradicability of filarial infections: a conceptual approach. Trends Parasitol. 2005, 21:88-96.
14. Duerr H.P., Eichner M. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa. Int. J. Parasitol. 2010, 40:641-650.
15. Duke B.O., Pacque M.C., Munoz B., Greene B.M., Taylor H.R. Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin. Bull. World Health Organ. 1991, 69:163-168.
16. Duke B.O., Zea-Flores G., Castro J., Cupp E.W., Munoz B. Effects of three-month doses of ivermectin on adult Onchocerca volvulus. Am. J. Trop. Med. Hyg. 1992, 46:189-194.
17. Duke B.O. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology 2005, 130:447-453.
18. Katabarwa M.N., Eyamba A., Chouaibou M., Enyong P., Kuete T., Yaya S., Yougouda A., Baldiagai J., Madi K., Andze G.O., Richards F. Does onchocerciasis transmission take place in hypoendemic areas? a study from the North Region of Cameroon. Trop. Med. Int. Health 2010, 15:645-652.
19. Klager S., Whitworth J.A., Post R.J., Chavasse D.C., Downham M.D. How long do the effects of ivermectin on adult Onchocerca volvulus persist?. Trop. Med. Parasitol. 1993, 44:305-310.
20. May R.M. Togetherness among schistosomes: its effects on the dynamics of the infection. Math. Biosci. 1977, 35:301-343.
21. May R.M., Woolhouse M.E. Biased sex ratios and parasite mating probabilities. Parasitology 1993, 107(Pt. 3):287-295.
22. Plaisier A.P., van Oortmarssen G.J., Remme J., Habbema J.D. The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop. 1991, 48:271-284.
23. Richards F., Hopkins D., Cupp E. Programmatic goals and approaches to onchocerciasis. Lancet 2000, 355:1663-1664.
24. Richards F.O., Boatin B., Sauerbrey M., Seketeli A. Control of onchocerciasis today: status and challenges. Trends Parasitol. 2001, 17:558-563.
25. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann. Trop. Med. Parasitol. 2008, 102(Suppl. 1):25-29.
26. Schulz-Key H., Soboslay P.T., Hoffmann W.H. Ivermectin-facilitated immunity. Parasitol. Today 1992, 8:152-153.
27. Soboslay P.T., Lüder C.G., Hoffmann W.H., Michaelis I., Helling G., Heuschkel C., Dreweck C.M., Blanke C.H., Pritze S., Banla M., Schulz-Key H. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin. Exp. Immunol. 1994, 96:238-244.
28. Thylefors B., Alleman M. Towards the elimination of onchocerciasis. Ann. Trop. Med. Parasitol. 2006, 100:733-746.
29. Winnen M., Plaisier A.P., Alley E.S., Nagelkerke N.J., van Oortmarssen G., Boatin B.A., Habbema J.D. Can ivermectin mass treatments eliminate onchocerciasis in Africa?. Bull. World Health Organ. 2002, 80:384-391.